Suppression of myeloid cell arginase activity leads to therapeutic response in Kras mutant lung cancer by activating anti-tumor immunity

被引：0
|
作者：
Miret, Juan J. [1 ]
Kirschmeier, Paul [1 ]
Wu, Min [1 ]
Huang, Wei [1 ]
Walker, William [1 ]
Palakurti, Sangeetha [1 ]
Saccomano, Nick [2 ]
Hammerman, Peter S. [1 ]
Wong, Kwok-Kin [3 ]
Akbay, Esra [4 ]
机构：
[1] Dana Farber Canc Inst, Belfer Inst, Boston, MA 02115 USA
[2] Array Biopharma, Boulder, CO USA
[3] NYU, Div Hematol & Med Oncol, Boston, MA USA
[4] UT Southwestern Med Ctr, Dallas, TX USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4065
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine
    Wagner, Samuel C.
    Ichim, Thomas E.
    Bogin, Vladimir
    Min, Wei-Ping
    Silva, Francisco
    Patel, Amit N.
    Kesari, Santosh
    ONCOTARGET, 2017, 8 (17) : 28595 - 28613
  • [42] T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity
    Foell, Jeurgen
    Hewes, Becker
    Mittler, Robert S.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (01) : 55 - 70
  • [43] Cell cycle activity correlates with increased anti-tumor immunity in diverse cancers
    Jiang, Shanmei
    He, Yin
    Li, Mengyuan
    Wang, Xiaosheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
  • [44] LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer
    Vakana, Eliza
    Pratt, Susan
    Blosser, Wayne
    Dowless, Michele
    Simpson, Nicholas
    Yuan, Xiu-Juan
    Jaken, Susan
    Manro, Jason
    Stephens, Jennifer
    Zhang, Youyan
    Huber, Lysiane
    Peng, Sheng-Bin
    Stancato, Louis F.
    ONCOTARGET, 2017, 8 (06) : 9251 - 9266
  • [45] A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression
    Tang, Zhen
    Hu, Jing
    Li, Xu-Chang
    Wang, Wei
    Zhang, Han-Yue
    Guo, Yu-Yao
    Shuai, Xin
    Chu, Qian
    Xie, Conghua
    Lin, Dandan
    Zhong, Bo
    DEVELOPMENTAL CELL, 2025, 60 (03)
  • [46] Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
    Cubillos-Ruiz, Juan R.
    Mohamed, Eslam
    Rodriguez, Paulo C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] DEMONSTRATION OF SPECIFIC CELL-MEDIATED ANTI-TUMOR IMMUNITY IN LUNG-CANCER TO AUTOLOGOUS TISSUE EXTRACTS
    DEAN, JH
    JERRELLS, TR
    CANNON, GB
    KIBRITE, A
    BAUMGARDNER, B
    WEESE, JL
    SILVA, J
    HERBERMAN, RB
    INTERNATIONAL JOURNAL OF CANCER, 1978, 22 (04) : 367 - 377
  • [48] Activin-A protects against lung cancer progression by potentiating anti-tumor immunity
    Morianos, I.
    Bostantzoglou, C.
    Gaga, M.
    Xanthou, G.
    Semitekolou, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1520 - 1520
  • [49] Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer
    Zhang, Dongze
    Xie, Jinjing
    Sun, Fangxin
    Xu, Ruyan
    Liu, Wenjun
    Xu, Jia
    Huang, Xue
    Zhang, Guangbo
    CANCER LETTERS, 2024, 589
  • [50] Combination of an ERK1/2 inhibitor (LY3214996) with VEGFR-2 inhibitor enhances anti-tumor activity in KRAS mutant non-small cell lung cancer
    Wu, Wenjuan
    Bhagwat, Shripad V.
    Jones, Bonita D.
    Swearingen, Michelle L.
    Falcon, Beverly L.
    McMillen, William T.
    Joseph, Sajan
    Buchanan, Sean
    Peng, Sheng-Bin
    Reinhard, Christoph
    Tiu, Ramon V.
    CANCER RESEARCH, 2018, 78 (13)
12345